{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T13:30:54Z","timestamp":1747920654803},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,12]]},"DOI":"10.7759\/cureus.43356","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T07:33:21Z","timestamp":1691825601000},"source":"Crossref","is-referenced-by-count":1,"title":["Assessing Thrombocytopenia and Chronic Liver Disease in Southeast Asia: A Multicentric Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Ramsha","family":"Sohail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran H","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mah","family":"Rukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S74612","article-title":"The pathophysiology of thrombocytopenia in chronic liver disease","volume":"8","author":"Mitchell O","year":"2016","unstructured":"Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016, 8:39-50. 10.2147\/HMER.S74612","journal-title":"Hepat Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i30.4061","article-title":"Thrombocytopenia in chronic liver disease: physiopathology and new therapeutic strategies before invasive procedures","volume":"28","author":"Gallo P","year":"2022","unstructured":"Gallo P, Terracciani F, Di Pasquale G, Esposito M, Picardi A, Vespasiani-Gentilucci U. Thrombocytopenia in chronic liver disease: physiopathology and new therapeutic strategies before invasive procedures. World J Gastroenterol. 2022, 28:4061-74. 10.3748\/wjg.v28.i30.4061","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup PG","year":"2021","unstructured":"Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al.. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 73:366-413. 10.1002\/hep.31646","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1806","article-title":"Impact of platelet count on perioperative bleeding in patients with cirrhosis undergoing surgical treatments of liver cancer","volume":"6","author":"Ronca V","year":"2022","unstructured":"Ronca V, Barabino M, Santambrogio R, et al.. Impact of platelet count on perioperative bleeding in patients with cirrhosis undergoing surgical treatments of liver cancer. Hepatol Commun. 2022, 6:423-34. 10.1002\/hep4.1806","journal-title":"Hepatol Commun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2012.03.252","article-title":"Adverse events of upper GI endoscopy","volume":"76","author":"Ben-Menachem T","year":"2012","unstructured":"Ben-Menachem T, Decker GA, Early DS, et al.. Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012, 76:707-18. 10.1016\/j.gie.2012.03.252","journal-title":"Gastrointest Endosc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh RN","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973, 60:646-9. 10.1002\/bjs.1800600817","journal-title":"Br J Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20824","article-title":"A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation","volume":"12","author":"Cholongitas E","year":"2006","unstructured":"Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006, 12:1049-61. 10.1002\/lt.20824","journal-title":"Liver Transpl"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0070","article-title":"Patient selection in an era of donor liver shortage: current US policy","volume":"2","author":"Wiesner RH","year":"2005","unstructured":"Wiesner RH. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol. 2005, 2:24-30. 10.1038\/ncpgasthep0070","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc M","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000, 31:864-71. 10.1053\/he.2000.5852","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000281","article-title":"Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more","volume":"21","author":"Kalra A","year":"2016","unstructured":"Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more. Curr Opin Organ Transplant. 2016, 21:120-6. 10.1097\/MOT.0000000000000281","journal-title":"Curr Opin Organ Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24063","article-title":"Serum sodium and survival benefit of liver transplantation","volume":"21","author":"Sharma P","year":"2015","unstructured":"Sharma P, Schaubel DE, Goodrich NP, Merion RM. Serum sodium and survival benefit of liver transplantation. Liver Transpl. 2015, 21:308-13. 10.1002\/lt.24063","journal-title":"Liver Transpl"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/30729","article-title":"Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level","volume":"60","author":"Ohta T","year":"2006","unstructured":"Ohta T, Sakaguchi K, Fujiwara A, et al.. Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. Acta Med Okayama. 2006, 60:77-84. 10.18926\/AMO\/30729","journal-title":"Acta Med Okayama"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx281","article-title":"Naswar (smokeless tobacco) use and the risk of oral cancer in Pakistan: a systematic review with meta-analysis","volume":"21","author":"Khan Z","year":"2019","unstructured":"Khan Z, Suliankatchi RA, Heise TL, Dreger S. Naswar (smokeless tobacco) use and the risk of oral cancer in Pakistan: a systematic review with meta-analysis. Nicotine Tob Res. 2019, 21:32-40. 10.1093\/ntr\/ntx281","journal-title":"Nicotine Tob Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet VJ","year":"1994","unstructured":"Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994, 19:1513-20. 10.1002\/hep.1840190629","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02889.x","article-title":"Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options","volume":"23","author":"Giannini EG","year":"2006","unstructured":"Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006, 23:1055-65. 10.1111\/j.1365-2036.2006.02889.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2018.11.001","article-title":"Prioritization for liver transplantation using the MELD score in Chile: inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator","volume":"18","author":"D\u00edaz LA","year":"2019","unstructured":"D\u00edaz LA, Norero B, Lara B, et al.. Prioritization for liver transplantation using the MELD score in Chile: inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator. Ann Hepatol. 2019, 18:325-30. 10.1016\/j.aohep.2018.11.001","journal-title":"Ann Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim WR","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, et al.. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008, 359:1018-26. 10.1056\/NEJMoa0801209","journal-title":"N Engl J Med"},{"key":"ref18","unstructured":"MDCalc. (2023). https.\/\/www.mdcalc.com\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.103026","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"72","author":"Mathew G","year":"2021","unstructured":"Mathew G, Agha R. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Ann Med Surg (Lond). 2021, 72:103026. 10.1016\/j.amsu.2021.103026","journal-title":"Ann Med Surg (Lond)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29887","article-title":"The high burden of alcoholic cirrhosis in privately insured persons in the United States","volume":"68","author":"Mellinger JL","year":"2018","unstructured":"Mellinger JL, Shedden K, Winder GS, et al.. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology. 2018, 68:872-82. 10.1002\/hep.29887","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico G","year":"2018","unstructured":"D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG. Clinical states of cirrhosis and competing risks. J Hepatol. 2018, 68:563-76. 10.1016\/j.jhep.2017.10.020","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico G","year":"2014","unstructured":"D'Amico G, Pasta L, Morabito A, et al.. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014, 39:1180-93. 10.1111\/apt.12721","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.191","article-title":"Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study","volume":"110","author":"Ratib S","year":"2015","unstructured":"Ratib S, Fleming KM, Crooks CJ, Walker AJ, West J. Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study. Am J Gastroenterol. 2015, 110:1149-58. 10.1038\/ajg.2015.191","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04473.x","article-title":"The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study","volume":"32","author":"Fleming KM","year":"2010","unstructured":"Fleming KM, Aithal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther. 2010, 32:1343-50. 10.1111\/j.1365-2036.2010.04473.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li J","year":"2019","unstructured":"Li J, Zou B, Yeo YH, et al.. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019, 4:389-98. 10.1016\/s2468-1253(19)30039-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath PS","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al.. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001, 33:464-70. 10.1053\/jhep.2001.22172","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i17.2069","article-title":"Prediction of liver cirrhosis, using diagnostic imaging tools","volume":"7","author":"Yeom SK","year":"2015","unstructured":"Yeom SK, Lee CH, Cha SH, Park CM. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol. 2015, 7:2069-79. 10.4254\/wjh.v7.i17.2069","journal-title":"World J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(94)80115-0","article-title":"Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study","volume":"21","author":"Realdi G","year":"1994","unstructured":"Realdi G, Fattovich G, Hadziyannis S, et al.. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol. 1994, 21:656-66. 10.1016\/s0168-8278(94)80115-0","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200309000-00001","article-title":"Predictors and implications of severe hypersplenism in patients with cirrhosis","volume":"326","author":"Liangpunsakul S","year":"2003","unstructured":"Liangpunsakul S, Ulmer BJ, Chalasani N. Predictors and implications of severe hypersplenism in patients with cirrhosis. Am J Med Sci. 2003, 326:111-6. 10.1097\/00000441-200309000-00001","journal-title":"Am J Med Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal N","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, et al.. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008, 48:1000-7. 10.1016\/j.jhep.2008.03.009","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/BF01308044","article-title":"Effect of portacaval anastomosis on hypersplenism","volume":"25","author":"Mutchnick MG","year":"1980","unstructured":"Mutchnick MG, Lerner E, Conn HO. Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci. 1980, 25:929-38. 10.1007\/BF01308044","journal-title":"Dig Dis Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1023\/a:1026634215918","article-title":"Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?","volume":"43","author":"Jabbour N","year":"1998","unstructured":"Jabbour N, Zajko A, Orons P, Irish W, Fung JJ, Selby RR. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?. Dig Dis Sci. 1998, 43:2459-62. 10.1023\/a:1026634215918","journal-title":"Dig Dis Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1989.tb00408.x","article-title":"Hematological complications of alcoholism","volume":"13","author":"Ballard HS","year":"1989","unstructured":"Ballard HS. Hematological complications of alcoholism. Alcohol Clin Exp Res. 1989, 13:706-20. 10.1111\/j.1530-0277.1989.tb00408.x","journal-title":"Alcohol Clin Exp Res"},{"key":"ref35","article-title":"A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion?","volume":"13","author":"Bordin G","year":"1995","unstructured":"Bordin G, Ballar\u00e9 M, Zigrossi P, et al.. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion?. Clin Exp Rheumatol. 1995, 13:S39-43.","journal-title":"Clin Exp Rheumatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(96)80021-3","article-title":"Thrombocytopenia associated with hepatitis C viral infection","volume":"24","author":"Nagamine T","year":"1996","unstructured":"Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol. 1996, 24:135-40. 10.1016\/s0168-8278(96)80021-3","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros PJ","year":"2002","unstructured":"Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 2002, 97:2040-5. 10.1111\/j.1572-0241.2002.05845.x","journal-title":"Am J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1972.tb05720.x","article-title":"Coagulation studies in patients with acute infectious hepatitis","volume":"22","author":"Gallus AS","year":"1972","unstructured":"Gallus AS, Lucas CR, Hirsh J. Coagulation studies in patients with acute infectious hepatitis. Br J Haematol. 1972, 22:761-71. 10.1111\/j.1365-2141.1972.tb05720.x","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/176585-assessing-thrombocytopenia-and-chronic-liver-disease-in-southeast-asia-a-multicentric-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:34Z","timestamp":1707508954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/176585-assessing-thrombocytopenia-and-chronic-liver-disease-in-southeast-asia-a-multicentric-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.43356","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,12]]}}}